ArticleAdvances in therapy2019

Second-Generation Trabecular Micro-Bypass Stents as Standalone Treatment for Glaucoma: A 36-Month Prospective Study.

Fritz H Hengerer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.